Noncontrast Brain MRI Effective for Monitoring Multiple Sclerosis

WEDNESDAY, March 13, 2019 -- For patients with multiple sclerosis (MS), use of a contrast-based agent at follow-up magnetic resonance imaging (MRI) does not change the diagnosis of interval disease progression, according to a study published online...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news